期刊文献+

穿膜融合多肽TAT-N24对胃癌细胞迁移的影响 被引量:1

Influence of Cell-permeable TAT-N24 Fusion Peptide on Cell Migration of Gastric Carcinoma Cells
下载PDF
导出
摘要 目的观察穿膜融合多肽TAT-N24对胃癌细胞MGC803迁移的影响。方法用纯化的融合多肽TAT-N24处理胃癌MGC803细胞,通过细胞迁移实验检测其对细胞运动迁移能力的影响,明胶酶谱实验观察其对肿瘤转移相关基因MMP9表达的影响。结果经TAT-N24多肽处理的MGC803细胞,其细胞迁移能力明显低于对照组细胞,差异具有统计学意义(P<0.05),但其对肿瘤转移相关基因MMP9的表达和分泌却没有影响。结论融合多肽TAT-N24能够抑制胃癌MGC803细胞的运动迁移能力,其在胃癌的治疗上可能具有潜在的应用前景。 Objective To observe the effects of cell - permeable TAT - N24 fusion peptide derived from p553, regulatory subunit of pbosphoinositide -3 kinase on cell migration of MGCS03 gastric carcinoma cells. Methods Gastric cancer cells MGC803 was treated with the purified fusion peptide TAT - N24. The ability of cell migration was detected by transwell migration assay. Expression of tumor metastasis associated gene MMP9 was observed by gelatin zymography. Results TAT - N24 fusion protein markedly resulted in decrease of the MGC803 cell migration compared with the control cells (P 〈 0.05 ). But it did not affect the expression and secretion of MMP9. Conclusion TAT - N24 fusion peptide could inhibit cell migration in gastric carcinoma MGC803 cells. It perhaps has potential clinical application in gastric carcinoma.
出处 《医学研究杂志》 2011年第10期69-71,共3页 Journal of Medical Research
基金 黑龙江省教育厅面上项目课题(11531431) 齐齐哈尔市科技局指导项目
关键词 TAT—N24 胃癌 细胞迁移 磷脂酰肌醇3-激酶(PI3K) TAT- N24 Gastric carcinoma Cell migration PI3K
  • 相关文献

参考文献11

  • 1Garcia - Echeverria C, Sellers WR. Drug discovery approaches targe- ting the PI3 K/Akt pathway in cancer[ J ]. Oncogene, 2008,27 (41) : 5511 - 5526.
  • 2Hu J, Liu S, Wang J, et al. Overexpression of the N - terminal end of the p55γ regulatory subunit of phosphatidylinositol 3 - kinase blocks cell cycle progression in gastric carcinoma cells [ J]. Int J On- col, 2005, 26(5) :1321 - 1327.
  • 3孙晓杰,王淑英,李珅,吴琦,赵玫,黄常志.PI3Kp55γ调节亚基N末端对乳腺癌细胞增殖和侵袭能力的影响[J].中华肿瘤防治杂志,2009,16(12):881-884. 被引量:4
  • 4Hu J, Xia X, Cheng A, et al. A peptide inhibitor derived from p55PIK phosphatidylinositol 3 -kinase regulatory subunit: a novel cancer therapy[ J ]. Mol Cancer Ther, 2008, 7 (12) :3719 -3728.
  • 5孙晓杰,赵玫,袁兴华,余权,黄常志.磷脂酰肌醇3激酶p55γ调节亚单位对胃癌细胞系MGC803细胞迁移的影响[J].中华医学杂志,2006,86(46):3269-3271. 被引量:3
  • 6Engelman JA. Targeting PI3 K signalling in cancer: opportunities, chal- lenges and limitations [ J ]. Nat Rev Cancer, 2009, 9 (8) :550 - 562.
  • 7De Laurentiis A, Pardo OE, Palamidessi A, et al. The catalytic class I(A) PI3K isoforms play divergent roles in breast cancer cell migra- tion [ J ]. Cell Signal, 2011,23 ( 3 ) :529 - 541.
  • 8Chen Y, Wei X, Guo C,et al. Runx3 suppresses gastric cancer me- tastasis through inactivation of MMP9 by up - regulation of TIMP - 1 [ J ]. Int J Cancer, 2010, Dec 2. doil0. 1002/ijc. 25831.
  • 9Qiao B, Johnson NW, Gao J. Epithelial - mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor - betal is snail family - dependent and correlates with matrix metallo- proteinase-2 and -9 expressions[J].Int J Oncol, 2010, 37(3): 663 - 668.
  • 10Peng B, Cao L, Ma X, et al. Meta - analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk [ J ]. Mutagenesis, 2010,25 (4) :371 - 379.

二级参考文献38

  • 1Chang F, Lee J T, Navolanic P M, et al. Involvement of PI3K/ Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation; a target for cancer chemotherapy[J].Leukemia, 2003, 17(3): 590-603.
  • 2Gao N, Flynn D C, Zhang Z, et al. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/ mTOR/pTOS6K1 signaling in human ovarian cancer cells[J].Am J Physiol Cell Physiol, 2004, 287(2): 281-291.
  • 3Arboleda M J, Lyons J F, Kabbinavar F F, et al. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells[J]. Cancer Res, 2003, 63 (1); 196-206.
  • 4Hu J, Liu S, Wang J, et al. Overexpression of the N-terminal end of the p55gamma regulatory subunit of phosphatidylinositol 3-kinase blocks cell cycle progression in gastric carcinoma cells [J].Int J Oncol, 2005, 26(5):1321-1327.
  • 5Xia X, Cheng A, Akinmade D, et al. The N-Terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3- kinase binds Rb and induces cell cycle arrest[J]. Mol Cell Biol, 2003, 23(5):1717-1725.
  • 6Fridman R, Fuerst T R, Bird R E, et al. Domain structure of human 72 kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions[J].J Biol Chem, 1992, 267(22) :15398-15405.
  • 7Suarez-Cuervo C, Merrell M A, Watson L, et al. Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice[J]. Clin Exp Metastasis, 2004, 21(6):525-533.
  • 8Saito K, Takeha S, Shiba K,et al. Clinicopathologic significance of urokinase receptor-and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis[J].Int J Cancer, 2000, 86 (1) :24-29.
  • 9Kuratomi Y, Nomizu M, Tanaka K, et al. Laminin gamma 1 chain peptide, C 16 (KAFDITYVRLKF), promotes migration, MMP 9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells[J].Br J Cancer, 2002, 86(7) :1169-1173.
  • 10Vivanco I, Sawyers CL The phosphatidylinositol 3 Kinase ANT pathway in human cancer[J]. Nat Rev Cancer, 2002,2(7):489-501.

共引文献10

同被引文献2

  • 1Nasu M,Carbone M,Gaudino G,et al.Ranpirnase Interferes with NF-KB Pathway and MMP9 Activity,Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenografl Growth[J].Genes Cancer,2011,2(5):576- 584.
  • 2Bekes EM,Deryugina EI, Kupriyanova TA,et al.Activation of pro-uPA Is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells[J].Neoplasia,2011, 13(9):806-821.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部